bicalutamide and abarelix

bicalutamide has been researched along with abarelix in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barzell, W; Campion, M; Fotheringham, N; Friedel, W; Garnick, MB; Gittleman, M; Pessis, D; Steidle, C; Trachtenberg, J1
Bhat, G; Bubley, GJ; Garnick, MB; Manola, J; Yannucci, J1

Trials

1 trial(s) available for bicalutamide and abarelix

ArticleYear
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.
    The Journal of urology, 2002, Volume: 167, Issue:4

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Humans; Leuprolide; Male; Middle Aged; Nitriles; Oligopeptides; Prostatic Neoplasms; Tosyl Compounds

2002

Other Studies

1 other study(ies) available for bicalutamide and abarelix

ArticleYear
The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
    The Journal of urology, 2006, Volume: 176, Issue:2

    Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Blood Glucose; Cholesterol; Fasting; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Nitriles; Oligopeptides; Prostatic Neoplasms; Tosyl Compounds

2006